Bleeding patients a concern for cardiologists
European cardiologists have called for more research into how bleeding can be reduced in patients suffering from acute coronary syndromes (ACS).
European cardiologists have called for more research into how bleeding can be reduced in patients suffering from acute coronary syndromes (ACS).
Members from the European Society of Cardiology (ESC) said bleeding associated with percutaneous coronary interventions (PCI) may be caused by predictors of bleeding and ischemic events, which is the a restriction of blood supply, generally due to factors in the blood vessels, resulting in damage or disfunction of the tissue.
They said one issue faced was the increasing need for treatment in older populations who are more likely to have decreased renal function.
Philippe Gabriel Steg, from the Centre Hospitalier Bichaut-Claude Bernard, in France, said it had become a more prevalent issue within the medical profession.
The call for more research followed a study in 2006 by John Eikelboom, which examined the link between bleeding and death or ischemic events in 34,146 patients with ACS.
He found patients who suffered major bleeds had a fivefold higher incidence of death in the first 30 days, and a 1.5 fold higher incidence of death between 30 days and six months.
The trials this year showed those whose bleeding was significantly reduced went on to show a subsequent reduction in mortality.
